Yue Teng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yue Teng has a total of 195 co-authors. Here are the top co-authors by number of shared publications:
Boyu Luo
School of Life Sciences, Tianjin University, Tianjin, 300072, China
7 shared publications- Tao Wang
School of Life Sciences, Tianjin University, Tianjin, China
6 shared publications - Baihan Lin
Hasso Plattner Institute for Digital Health, Icahn School of Medicine at Mount Sinai
4 shared publications Shan Yang
State Key Laboratory of Pathogen and Biosecurity Beijing Institute of Microbiology and Epidemiology Beijing China
4 shared publicationsTuoyu Liu
State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, 100071, China
4 shared publications- Yigang Tong
Beijing University of Chemical Technology
4 shared publications
Latest Publications
- 16 July 2026
- Published by Springer Nature in Science China Life Sciences
- Vol. 69 (11) , 3868-3885
5-FU chemotherapy induces functional CD7+ and IL7R+ CTLs infiltration to suppress colorectal tumor progression
5-Fluorouracil (5-FU) is the cornerstone of chemotherapy for patients with advanced colorectal cancer. 5-FU acts primarily by inhibiting thymidylate synthase to prevent DNA and RNA synthesis, causing apoptosis in rapidly dividing cancer cells. Emerging literature indicates that 5-FU also suppresses tumor development by activating tumor-reactive T cells. However, the mechanism underlying 5-FU function in T cell activation in human colorectal cancer remains incompletely understood. In a comparative screening of human colorectal tumor tissues, we found that the levels of CD7+ cytotoxic T lymphocytes (CTLs) and IL7R+ CTLs subsets were significantly lower in human colorectal tumor tissues compared to matched adjacent nonneoplastic colon tissues. As expected, 5-FU therapy effectively suppressed colorectal tumor growth and enhanced total CTLs tumor infiltration in tumor-bearing mice. Analysis of tumor-infiltrating CTLs revealed that 5-FU therapy induced CD7+ and IL7R+ CTLs differentiation in the mouse colorectal tumor microenvironment. Mechanistically, p53 regulates CD7 and IL7R expression in CTLs by directly binding to the hCD7 and hCD127 promoters, respectively. Functionally, IL7R+CD8+ T cells exhibited improved cytotoxicity with elevated expression of T cell effector genes both in vivo and ex vivo in the mouse colorectal tumor microenvironment. More importantly, 5-FU therapy remarkably promoted CD7+ and IL7R+ CTLs tumor infiltration in colorectal cancer patients, as well as facilitated the infiltration of IL7R+ CTLs subsets in colorectal tumor-bearing mice. Overall, our findings determine that colon cancer suppresses the infiltration of CD7+ or IL7R+ CTLs into tumor microenvironment as a mechanism of immune evasion. 5-FU therapy represses colon cancer progression at least in part through activating p53 to foster CD7+ and IL7R+ CTLs tumor infiltration, thus proposing a new perspective for the anti-tumor mechanism of 5-FU and a novel, promising therapeutic route by expanding CD7+ and IL7R+ CTLs to improve the response to 5-FU chemotherapy.
- 16 July 2026
- Published by Springer Nature in Science China Life Sciences
- Vol. 69 (11) , 3868-3885
5-FU chemotherapy induces functional CD7+ and IL7R+ CTLs infiltration to suppress colorectal tumor progression
5-Fluorouracil (5-FU) is the cornerstone of chemotherapy for patients with advanced colorectal cancer. 5-FU acts primarily by inhibiting thymidylate synthase to prevent DNA and RNA synthesis, causing apoptosis in rapidly dividing cancer cells. Emerging literature indicates that 5-FU also suppresses tumor development by activating tumor-reactive T cells. However, the mechanism underlying 5-FU function in T cell activation in human colorectal cancer remains incompletely understood. In a comparative screening of human colorectal tumor tissues, we found that the levels of CD7+ cytotoxic T lymphocytes (CTLs) and IL7R+ CTLs subsets were significantly lower in human colorectal tumor tissues compared to matched adjacent nonneoplastic colon tissues. As expected, 5-FU therapy effectively suppressed colorectal tumor growth and enhanced total CTLs tumor infiltration in tumor-bearing mice. Analysis of tumor-infiltrating CTLs revealed that 5-FU therapy induced CD7+ and IL7R+ CTLs differentiation in the mouse colorectal tumor microenvironment. Mechanistically, p53 regulates CD7 and IL7R expression in CTLs by directly binding to the hCD7 and hCD127 promoters, respectively. Functionally, IL7R+CD8+ T cells exhibited improved cytotoxicity with elevated expression of T cell effector genes both in vivo and ex vivo in the mouse colorectal tumor microenvironment. More importantly, 5-FU therapy remarkably promoted CD7+ and IL7R+ CTLs tumor infiltration in colorectal cancer patients, as well as facilitated the infiltration of IL7R+ CTLs subsets in colorectal tumor-bearing mice. Overall, our findings determine that colon cancer suppresses the infiltration of CD7+ or IL7R+ CTLs into tumor microenvironment as a mechanism of immune evasion. 5-FU therapy represses colon cancer progression at least in part through activating p53 to foster CD7+ and IL7R+ CTLs tumor infiltration, thus proposing a new perspective for the anti-tumor mechanism of 5-FU and a novel, promising therapeutic route by expanding CD7+ and IL7R+ CTLs to improve the response to 5-FU chemotherapy.
- Open Access
- 21 April 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (4) , e0004426
Nondestructive tracking of viral infections by viral protein-initiated fluorescent sensors
Real-time tracking of viral infection processes is critical for elucidating the pathogenic mechanisms and therapeutic targets. A more detailed understanding of viral movement in the extracellular environment in vivo as well as in extraplasmic space requires the development of a tool capable of stable fluorescence without affecting the virus’s own physiological chemotaxis. Herein, we report a viral protein-based enhanced targeting (PBET) fluorescent sensor that can image the infection process of live viruses in spaces adjacent to living cells and in vivo environments. Experimental and computational studies have shown that PBET sensors are capable of spontaneous dimer formation and have an enhanced ability to target the electrostatic interactions of functionalized motifs through the restriction of intramolecular motions. The PBET sensor effectively ensured that the attachment process did not affect the physicochemical properties of the virus because of the molecularly induced targeting buffer effect (MITB) binding to the viral surface proteins. Meanwhile, fluorescence intensity, persistence, and minimum labeling concentration, all several times higher than existing fluorescent dyes, ensure that this sensor element can stably and efficiently track viral particle infection timelines at the cellular and tissue levels. This provides a novel platform strategy for antiviral localization studies and the diagnosis of infected areas in patients. IMPORTANCE: Real-time viral tracer technology plays a driving role in deconstructing viral infections by demonstrating the infection process and the potential binding regions in multiple dimensions. However, the methods of labeling viruses are still limited to traditional fluorescent protein labeling and loaded fluorescent molecules. These schemes have undoubtedly had a noticeable impact on simple viral structures, with labeled viruses showing fluctuations in infectivity. Therefore, it is important to nondestructively perform the dynamic tracing of viruses. By integrating the existing protein fluorescent labeling schemes and fluorescent molecular charge transfer theory, this study builds a system with nondestructive labeling, dynamic tracing, and labeling mechanism analysis of viruses, which is of great scientific value in the prevention of infectious diseases.
- 21 April 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (4) , e0004426
Open AccessNondestructive tracking of viral infections by viral protein-initiated fluorescent sensors
Real-time tracking of viral infection processes is critical for elucidating the pathogenic mechanisms and therapeutic targets. A more detailed understanding of viral movement in the extracellular environment in vivo as well as in extraplasmic space requires the development of a tool capable of stable fluorescence without affecting the virus’s own physiological chemotaxis. Herein, we report a viral protein-based enhanced targeting (PBET) fluorescent sensor that can image the infection process of live viruses in spaces adjacent to living cells and in vivo environments. Experimental and computational studies have shown that PBET sensors are capable of spontaneous dimer formation and have an enhanced ability to target the electrostatic interactions of functionalized motifs through the restriction of intramolecular motions. The PBET sensor effectively ensured that the attachment process did not affect the physicochemical properties of the virus because of the molecularly induced targeting buffer effect (MITB) binding to the viral surface proteins. Meanwhile, fluorescence intensity, persistence, and minimum labeling concentration, all several times higher than existing fluorescent dyes, ensure that this sensor element can stably and efficiently track viral particle infection timelines at the cellular and tissue levels. This provides a novel platform strategy for antiviral localization studies and the diagnosis of infected areas in patients. IMPORTANCE: Real-time viral tracer technology plays a driving role in deconstructing viral infections by demonstrating the infection process and the potential binding regions in multiple dimensions. However, the methods of labeling viruses are still limited to traditional fluorescent protein labeling and loaded fluorescent molecules. These schemes have undoubtedly had a noticeable impact on simple viral structures, with labeled viruses showing fluctuations in infectivity. Therefore, it is important to nondestructively perform the dynamic tracing of viruses. By integrating the existing protein fluorescent labeling schemes and fluorescent molecular charge transfer theory, this study builds a system with nondestructive labeling, dynamic tracing, and labeling mechanism analysis of viruses, which is of great scientific value in the prevention of infectious diseases.
- Open Access
- 25 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Bioorthogonal optimized virus immuno-nanomedicine (BOVIN)
The failure of tumour immunotherapy can be attributed to two primary factors: the limited immunogenicity of tumour cells and the immunosuppressive characteristics of the tumour microenvironment. Recent research indicates that cancer patients infected with respiratory viruses exhibit a positive antitumour response, as the activated host immune system. Here we show a bioorthogonal optimized virus immuno-nanomedicine (BOVIN) that uses nonpathogenic recombinant virus immuno-nanomedicine (VIN) for the targeted therapy of solid tumours. The influenza viruses (A/WSN/1933(WSN)) induce immunogenic cell death (ICD) in tumour cells by triggering a stress response mediated by integrated mitochondrial dysregulation. Furthermore, the surface modification of WSN with lactate oxidase enables the consumption of lactate to produce hydrogen peroxide, which synergistically enhance ICD activation. This leads to the attraction and significant activation of antigen-presenting cells in the tumour region through the exposure of calreticulin and secretion of high mobility group box 1. Additionally, the BOVIN triggers the tumour ICD, significantly enhances CD8+ T-cell tumour infiltration, strengthens the sensitivity of immune checkpoint blockers, and thus activates anti-tumour immune memory to effectively inhibit tumour recurrence after surgery. In conclusion, bioorthogonal nonpathogenic recombinant VIN reverses the immunosuppressed state of malignant cells, offering potential for improved tumour immunotherapy.
- 25 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessBioorthogonal optimized virus immuno-nanomedicine (BOVIN)
The failure of tumour immunotherapy can be attributed to two primary factors: the limited immunogenicity of tumour cells and the immunosuppressive characteristics of the tumour microenvironment. Recent research indicates that cancer patients infected with respiratory viruses exhibit a positive antitumour response, as the activated host immune system. Here we show a bioorthogonal optimized virus immuno-nanomedicine (BOVIN) that uses nonpathogenic recombinant virus immuno-nanomedicine (VIN) for the targeted therapy of solid tumours. The influenza viruses (A/WSN/1933(WSN)) induce immunogenic cell death (ICD) in tumour cells by triggering a stress response mediated by integrated mitochondrial dysregulation. Furthermore, the surface modification of WSN with lactate oxidase enables the consumption of lactate to produce hydrogen peroxide, which synergistically enhance ICD activation. This leads to the attraction and significant activation of antigen-presenting cells in the tumour region through the exposure of calreticulin and secretion of high mobility group box 1. Additionally, the BOVIN triggers the tumour ICD, significantly enhances CD8+ T-cell tumour infiltration, strengthens the sensitivity of immune checkpoint blockers, and thus activates anti-tumour immune memory to effectively inhibit tumour recurrence after surgery. In conclusion, bioorthogonal nonpathogenic recombinant VIN reverses the immunosuppressed state of malignant cells, offering potential for improved tumour immunotherapy.
- Open Access
- 15 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
DLFea4AMPGen de novo design of antimicrobial peptides by integrating features learned from deep learning models
Deep learning models show promise in accelerating the design and optimization of antimicrobial peptides (AMPs), but current methods face challenges, such as low success rates, or large virtual library scales. In this study, we introduce DLFea4AMPGen, a bioactive peptide design strategy that leverages deep learning models to identify and extract key features associated with antimicrobial peptide activity. This approach enables the generation of peptide sequences with potential bioactivities. Using the SHapley Additive exPlanations (SHAP) method, we quantify the contribution of each amino acid in multifunctional peptides with potential antibacterial, antifungal, and antioxidant activities. Key feature fragments (KFFs) with the highest average contributions are extracted and classified into four subfamilies based on amino acid frequency. These high-frequency amino acids are systematically arranged to generate a plausible sequence subspace for candidate peptides, from which 16 representative sequences were selected for experimental validation. The results show that 75% (12/16) of the sequences exhibited at least two types of activity. Notably, D1 exhibits broad-spectrum antimicrobial activity, including efficacy against multidrug-resistant clinical pathogenic isolates both in vitro and in vivo. This proof-of-concept study underscores the potential of the DLFea4AMPGen platform for efficient design and screening of bioactive peptides, showcasing its value in AMP research.
- 15 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Open AccessDLFea4AMPGen de novo design of antimicrobial peptides by integrating features learned from deep learning models
Deep learning models show promise in accelerating the design and optimization of antimicrobial peptides (AMPs), but current methods face challenges, such as low success rates, or large virtual library scales. In this study, we introduce DLFea4AMPGen, a bioactive peptide design strategy that leverages deep learning models to identify and extract key features associated with antimicrobial peptide activity. This approach enables the generation of peptide sequences with potential bioactivities. Using the SHapley Additive exPlanations (SHAP) method, we quantify the contribution of each amino acid in multifunctional peptides with potential antibacterial, antifungal, and antioxidant activities. Key feature fragments (KFFs) with the highest average contributions are extracted and classified into four subfamilies based on amino acid frequency. These high-frequency amino acids are systematically arranged to generate a plausible sequence subspace for candidate peptides, from which 16 representative sequences were selected for experimental validation. The results show that 75% (12/16) of the sequences exhibited at least two types of activity. Notably, D1 exhibits broad-spectrum antimicrobial activity, including efficacy against multidrug-resistant clinical pathogenic isolates both in vitro and in vivo. This proof-of-concept study underscores the potential of the DLFea4AMPGen platform for efficient design and screening of bioactive peptides, showcasing its value in AMP research.
- Open Access
- 21 June 2025
- Published by Elsevier in Science Bulletin
- Vol. 71 (1) , 55-59
RG7388 inhibits SFTSV replication by suppressing MDM2-mediated p53 degradation and preventing apoptosome disruption
- 21 June 2025
- Published by Elsevier in Science Bulletin
- Vol. 71 (1) , 55-59
Open AccessRG7388 inhibits SFTSV replication by suppressing MDM2-mediated p53 degradation and preventing apoptosome disruption
- Open Access
- 1 March 2025
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 10 (1) , 174-184
Mechanistic insights into the orthogonal functionality of an AHL-mediated quorum-sensing circuit in Yersinia pseudotuberculosis
YpsR, a pivotal regulatory protein in the quorum-sensing (QS) of Yersinia pseudotuberculosis(Y. pstb), is essential for molecular signaling, yet its molecular mechanisms remain poorly understood. Herein, this study systematically investigates the interactions between YpsR and acyl-homoserine lactones (AHLs), shedding light on the selective mechanism of YpsR to various AHL molecules. Using molecular docking and surface plasmon resonance (SPR) analysis, we confirmed YpsR's binding affinities, with the strongest observed for 3OC6-HSL, which notably inhibited Y. pstb growth. Additionally, we engineered a whole-cell biosensor based on YpsR-AHL interaction, which exhibited sensitivity to the signal molecule 3OC6-HSL produced by Y. pstb. Furthermore, key YpsR residues (S32, Y50, W54, D67) involved in AHL binding were identified and validated. Overall, this research elucidates the mechanisms of QS signal recognition in Y. pstb, providing valuable insights that support the development of diagnostic tools for detecting Y. pstb infections.
- 1 March 2025
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 10 (1) , 174-184
Open AccessMechanistic insights into the orthogonal functionality of an AHL-mediated quorum-sensing circuit in Yersinia pseudotuberculosis
YpsR, a pivotal regulatory protein in the quorum-sensing (QS) of Yersinia pseudotuberculosis(Y. pstb), is essential for molecular signaling, yet its molecular mechanisms remain poorly understood. Herein, this study systematically investigates the interactions between YpsR and acyl-homoserine lactones (AHLs), shedding light on the selective mechanism of YpsR to various AHL molecules. Using molecular docking and surface plasmon resonance (SPR) analysis, we confirmed YpsR's binding affinities, with the strongest observed for 3OC6-HSL, which notably inhibited Y. pstb growth. Additionally, we engineered a whole-cell biosensor based on YpsR-AHL interaction, which exhibited sensitivity to the signal molecule 3OC6-HSL produced by Y. pstb. Furthermore, key YpsR residues (S32, Y50, W54, D67) involved in AHL binding were identified and validated. Overall, this research elucidates the mechanisms of QS signal recognition in Y. pstb, providing valuable insights that support the development of diagnostic tools for detecting Y. pstb infections.
- Open Access
- 1 December 2024
- Published by Science China Press., Co. Ltd. in Chinese Science Bulletin
- Vol. 69 (36) , 5213-5224
Research progress of bacterial quorum sensing systems in synthetic biology applications
群体感应系统是一种能够感应细胞密度的调控相关靶基因表达的自诱导系统,细菌利用群体感应系统实现细胞间通讯,以响应邻近群落的种群密度和物种间和物种内组成的变化,调控菌体的生理特性,对细菌群体的稳定性具有重要作用。群体感应系统因其结构简单、机理清晰而广泛应用于合成生物学的研究。本综述旨在加深对群体感应系统调控机制的理解。概述了群体感应系统的工作原理,基于不同自诱导因子对群体感应系统进行分类;分析了其多样性、串扰和正交性等特点;着重阐述了群体感应系统用于生物传感器,特别是肠道和皮肤菌群监测,以及构建合成生物学群落等合成生物学中的应用,以期为更加全面且深入探究群体感应系统调控机制和扩大其在合成生物学中的应用范围提供帮助。
- 1 December 2024
- Published by Science China Press., Co. Ltd. in Chinese Science Bulletin
- Vol. 69 (36) , 5213-5224
Open AccessResearch progress of bacterial quorum sensing systems in synthetic biology applications
群体感应系统是一种能够感应细胞密度的调控相关靶基因表达的自诱导系统,细菌利用群体感应系统实现细胞间通讯,以响应邻近群落的种群密度和物种间和物种内组成的变化,调控菌体的生理特性,对细菌群体的稳定性具有重要作用。群体感应系统因其结构简单、机理清晰而广泛应用于合成生物学的研究。本综述旨在加深对群体感应系统调控机制的理解。概述了群体感应系统的工作原理,基于不同自诱导因子对群体感应系统进行分类;分析了其多样性、串扰和正交性等特点;着重阐述了群体感应系统用于生物传感器,特别是肠道和皮肤菌群监测,以及构建合成生物学群落等合成生物学中的应用,以期为更加全面且深入探究群体感应系统调控机制和扩大其在合成生物学中的应用范围提供帮助。
- Open Access
- 27 June 2024
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 137 (17) , 2092-2098
Enhancing antimicrobial resistance detection with MetaGeneMiner: Targeted gene extraction from metagenomes
Background: Accurately and efficiently extracting microbial genomic sequences from complex metagenomic data is crucial for advancing our understanding in fields such as clinical diagnostics, environmental microbiology, and biodiversity. As sequencing technologies evolve, this task becomes increasingly challenging due to the intricate nature of microbial communities and the vast amount of data generated. Especially in intensive care units (ICUs), infections caused by antibiotic-resistant bacteria are increasingly prevalent among critically ill patients, significantly impacting the effectiveness of treatments and patient prognoses. Therefore, obtaining timely and accurate information about infectious pathogens is of paramount importance for the treatment of patients with severe infections, which enables precisely targeted anti-infection therapies, and a tool that can extract microbial genomic sequences from metagenomic dataset would be of help. Methods: We developed MetaGeneMiner to help with retrieving specific microbial genomic sequences from metagenomes using a k-mer-based approach. It facilitates the rapid and accurate identification and analysis of pathogens. The tool is designed to be user-friendly and efficient on standard personal computers, allowing its use across a wide variety of settings. We validated MetaGeneMiner using eight metagenomic samples from ICU patients, which demonstrated its efficiency and accuracy. Results: The software extensively retrieved coding sequences of pathogens Acinetobacter baumannii and herpes simplex virus type 1 and detected a variety of resistance genes. All documentation and source codes for MetaGeneMiner are freely available at https://gitee.com/sculab/MetaGeneMiner. Conclusions: It is foreseeable that MetaGeneMiner possesses the potential for applications across multiple domains, including clinical diagnostics, environmental microbiology, gut microbiome research, as well as biodiversity and conservation biology. Particularly in ICU settings, MetaGeneMiner introduces a novel, rapid, and precise method for diagnosing and treating infections in critically ill patients. This tool is capable of efficiently identifying infectious pathogens, guiding personalized and precise treatment strategies, and monitoring the development of antibiotic resistance, significantly impacting the diagnosis and treatment of severe infections.
- 27 June 2024
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 137 (17) , 2092-2098
Open AccessEnhancing antimicrobial resistance detection with MetaGeneMiner: Targeted gene extraction from metagenomes
Background: Accurately and efficiently extracting microbial genomic sequences from complex metagenomic data is crucial for advancing our understanding in fields such as clinical diagnostics, environmental microbiology, and biodiversity. As sequencing technologies evolve, this task becomes increasingly challenging due to the intricate nature of microbial communities and the vast amount of data generated. Especially in intensive care units (ICUs), infections caused by antibiotic-resistant bacteria are increasingly prevalent among critically ill patients, significantly impacting the effectiveness of treatments and patient prognoses. Therefore, obtaining timely and accurate information about infectious pathogens is of paramount importance for the treatment of patients with severe infections, which enables precisely targeted anti-infection therapies, and a tool that can extract microbial genomic sequences from metagenomic dataset would be of help. Methods: We developed MetaGeneMiner to help with retrieving specific microbial genomic sequences from metagenomes using a k-mer-based approach. It facilitates the rapid and accurate identification and analysis of pathogens. The tool is designed to be user-friendly and efficient on standard personal computers, allowing its use across a wide variety of settings. We validated MetaGeneMiner using eight metagenomic samples from ICU patients, which demonstrated its efficiency and accuracy. Results: The software extensively retrieved coding sequences of pathogens Acinetobacter baumannii and herpes simplex virus type 1 and detected a variety of resistance genes. All documentation and source codes for MetaGeneMiner are freely available at https://gitee.com/sculab/MetaGeneMiner. Conclusions: It is foreseeable that MetaGeneMiner possesses the potential for applications across multiple domains, including clinical diagnostics, environmental microbiology, gut microbiome research, as well as biodiversity and conservation biology. Particularly in ICU settings, MetaGeneMiner introduces a novel, rapid, and precise method for diagnosing and treating infections in critically ill patients. This tool is capable of efficiently identifying infectious pathogens, guiding personalized and precise treatment strategies, and monitoring the development of antibiotic resistance, significantly impacting the diagnosis and treatment of severe infections.
- 13 June 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 673, 765-780
Surface nanocoating-based universal platform for programmed delivery of microorganisms in complicated digestive tract
- 13 June 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 673, 765-780
Surface nanocoating-based universal platform for programmed delivery of microorganisms in complicated digestive tract
- Open Access
- 15 June 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (3) , e0423322
CRISPR/Cas12a Technology Combined with Recombinase Polymerase Amplification for Rapid and Portable Monkeypox Virus Detection
- 15 June 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (3) , e0423322
Open AccessCRISPR/Cas12a Technology Combined with Recombinase Polymerase Amplification for Rapid and Portable Monkeypox Virus Detection